Baxter Recalls Sodium Chloride Injection Due to Particulate Matter and Sterility Concerns
Baxter Healthcare is recalling 0.9% Sodium Chloride Injection USP due to complaints of particulate matter, leaks, and missing port protectors.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility for an intravenous product, which poses a significant risk of serious injury or infection.
Plain-English summary
Baxter Healthcare Corporation is recalling 189,912 containers of 0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container. The affected product is identified by Lot # C964601 and has an expiration date of 4/30/2016. The product was distributed in Texas and Tennessee.
The recall was initiated after the firm received a complaint from a customer regarding the presence of particulate matter, leaky containers, and missing port protectors. These issues raise concerns about the lack of assurance of sterility for the intravenous solution.
Healthcare providers and patients should stop using the affected lots of Sodium Chloride Injection and contact Baxter Healthcare or their local FDA office for further instructions. Consumers should not use the product if it is from the specified lot and distribution area.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Baxter Healthcare Corp.
- Category
- Drug — IV Solution
- Affected units
- 189,912
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C964601
- Exp 4/30/2016
Distribution
Related recalls
Same brand · SODIUM CHLORIDE
- HighSpectra sodium chloride ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighBD-distributed 50 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 1,000 mL sodium chloride bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 50 mL sodium chloride injection recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- SevereSodium Chloride Injection Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-04-15
Same manufacturer · Baxter Healthcare Corp.
See all →- HighBaxter Amia Automated Peritoneal Dialysis Set Recalled for Flow Issues
FDA (Devices) · 2017-09-20
- ModerateBaxter Recalls SIGMA Spectrum Infusion Pump Rear Case Assemblies
FDA (Devices) · 2016-12-07
- ModerateBaxter Recalls Sigma Spectrum Infusion Pumps Due to Speaker Failure Risk
FDA (Devices) · 2016-12-07
- ModerateBaxter SIGMA Spectrum Infusion Pump Recall for Speaker Failure
FDA (Devices) · 2016-12-07
- HighBaxter Recalls Revaclear MAX Dialyzers Due to Potential Particulate Matter
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26